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Human cytomegalovirus (HCMV) infection of fibroblasts induces the proinflammatory mediator macrophage migration
inhibitory factor (MIF). Our in vitro experiments show that active HCMV infection alone is required to induce an early and
sustained induction of MIF mRNA and protein production. Unlike in other infection models, in which MIF has been described
to be released from preformed stores, our data conclusively show that HCMV infection triggers de novo synthesis and
subsequent secretion of MIF. The kinetics of MIF protein production during HCMV infection points to an efficacious immune
modulation, in which lymphocytes and monocytes are initially recruited by the early release of chemokines to sites ofs of MIINTRODUCTION
Human cytomegalovirus (HCMV) infection is associ-
ated with a diverse spectrum of complications. Primary
and reactivation infections are a significant cause of
morbidity among transplant recipients, individuals with
immunodeficiency syndromes, and cancer patients.
Other complications associated with HCMV infection
suggest interactions with host immune and cellular
mechanisms. For example, HCMV infection has been
shown to be a risk factor for graft rejection among car-
diac and renal transplant recipients (Grattan et al., 1889;
Rubin et al., 1985), and the ability of HCMV to actually
accelerate graft rejection has been demonstrated in an-
imal models (Carlquist et al., 1993). The ability of this
virus to modulate the immune system of the host may
directly contribute to the complications seen in HCMV
infection. In fact, previous studies have identified several
physiologic responses of cultured cells to HCMV infec-
tion, including the induction of adhesion molecules (Crai-
gen et al., 1996) and cytokine production, such as inter-
leukin (IL)-6 (Almeida et al., 1994; Carlquist et al., 1999),
RANTES (Michelson et al., 1997), and IL-8 (Craigen et al.,
1997).
MIF was originally described as a product of activated
T cells that inhibited the random migration of guinea pig
peritoneal macrophages in vitro and promoted macro-
phage accumulation in the delayed-type hypersensitivity
(DTH) reaction (David, 1966). However, despite the long-
standing association of MIF with the DTH reaction, it is
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32only recently that the functional role of MIF in the im-
mune and inflammatory responses has been deter-
mined. In vivo blocking studies have shown that MIF
plays a pivotal role in the tuberculin-induced skin DTH
reaction and endotoxic shock (Bernhagen et al., 1993,
1996). The latter study has been further substantiated by
a recent report demonstrating that mice lacking the MIF
gene were protected against endotoxin-induced lethal
shock (Bozza et al., 1999). A unique property of MIF is
that it also is released from immune cells in response to
stimulation by glucocorticoids and can act as a counter-
regulator of glucocorticoid action (Calandra et al., 1995).
MIF has also been shown to play an important role in
primary antigenic and mitogenic stimulation of T-cell
activation and T-cell-dependent antibody production
(Bacher et al., 1996). Given the significant biologic and
pathoetiologic functions of MIF, we chose to study the
effects of HCMV infection on human foreskin fibroblasts,
with respect to this cytokine.
RESULTS
To examine a possible modulation of MIF in human
foreskin fibroblasts (HFF) following HCMV infection, we
first studied the expression of MIF mRNA. In uninfected
fibroblasts MIF steady-state mRNA levels were detected
at the beginning of the incubation period and declined at
later time points (Fig.1). In contrast, MIF transcripts were
readily induced 6 h after HCMV infection, always dipped
down at 12 h, and went up again, reaching maximum
levels at the end of the infection course (Fig. 1). The
experiment described above used an unpurified virus
stock, i.e., an infected cell supernatant, as the source ofinfection and locally activated by increasing concentration
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virus. Such a virus stock almost certainly contains vari-
ous cytokines and other signaling molecules that have
been described during the course of viral infection.
These factors in the virus stock may be responsible for,
or contribute to, the observed induction of MIF mRNA. To
differentiate between direct induction of MIF by the virus
and induction by a contaminating factor, the crude virus
stock was purified by a high- speed centrifugation of
virions through a sucrose cushion, separating the parti-
cles from low-weight contaminants. After determination
of its titer, the purified virus stock was used to infect
HFFs at a m.o.i. of 3; this m.o.i. was the same as used for
infection with the unpurified virus stock. A similar expres-
sion pattern was observed when the cells were infected
with a purified virus preparation (Fig. 1). When the cul-
tures were incubated with the supernatants of the puri-
fied virus preparation, we observed only an initial in-
crease of MIF mRNA levels at 6 h which declined at later
time points (Fig. 1). To determine whether infectious virus
is required to stimulate MIF production, an aliquot of the
virus preparation was subjected to UV irradiation. Kinet-
ics of MIF mRNA in the presence of UV-treated virus
were similar to the incubation with supernatants of pu-
rified virus preparation, i.e., we detected initial increase
of the MIF mRNA signal at 6 h which tailed off at later
time points (Fig. 1).
We next analyzed the extracellular MIF production
under the experimental conditions described above by
Western blot analysis. We detected the same strong
induction of extracellular MIF production with the unpu-
rified or gradient- purified virus preparation, whereas the
incubation with the supernatants of the purified virus, or
UV-inactivated virus failed to induce enhanced levels of
extracellular MIF in HFF cells (Fig. 2).
FIG. 2. Kinetics of extracellular MIF production in supernatants of
normal fibroblasts (Ctrl) and after infection with unpurified virus
(HCMV), purified virus (pur. HCMV), supernatant of purified virus (SN
pur. HCMV), UV-inactivated virus (HCMV-UV), and PAA-treated virus
(HCMV-PAA). Supernatants were prepared as described under Mate-
rials and Methods. Ten-microliter aliquots of the supernatants at the
indicated times were electrophoresed and transferred onto nitrocellu-
lose membranes, and the MIF content was analyzed by reaction with
an anti-MIF antibody as described under Materials and Methods. rMIF
(5 ng) was electrophoresed as standard (STD).
FIG. 1. Kinetics of MIF mRNA production in primary human fibro-
blasts in control cells (Ctrl) and after infection with crude virus prepa-
ration (HCMV), gradient purified virus (HCMV pur.), supernatants of
gradient purified virus (HCMV SN pur.), and UV-inactivated virus
(HCMV-UV). All infections were carried out at a m.o.i. of 3. Total RNA
was isolated from the cells before (0) and 6, 12, 24, 48, 72, and 96 h after
incubation. Five micrograms of total RNA per sample was analyzed for
hybridization with a DIG-labeled cRNA probe for human MIF. To confirm
integrity and equal loading of the RNA, 5 g RNA per samples was
blotted onto nitrocellulose membrane and stained with methylene blue.
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To address the question whether the HCMV-depen-
dent induction of MIF protein production is a late event of
the viral cycle, we specifically blocked HCMV DNA syn-
thesis by addition of PAA. Western blot analyses showed
conclusively that MIF protein was also induced under
these conditions, though appeared to be delayed in com-
parison to the infection with virus alone (Fig. 2).
To further substantiate our findings of a virus-depen-
dent induction of extracellular MIF production in HFF, we
also analyzed the supernatants of cultures from unin-
fected control cells, HCMV-infected cells, HCMV-UV
treated cells, and HCMV-PAA treated cells by a specific
MIF sandwich ELISA (Fig. 3). The ELISA data confirmed
the Western blot results and showed a rapid and sus-
tained extracellular MIF protein accumulation only when
the cells were incubated in the presence of virus (Fig. 3).
Delayed MIF secretion was detected when PAA was
added to the virus infection. In contrast, only small
amounts of MIF were detected within the supernatants of
uninfected or UV-inactivated cultures at the end of the
incubation period (Fig. 3).
The in vitro induction of MIF protein during the course
of the HCMV infection was further substantiated and
extended by immunofluorescence (Figs. 4A and 4B). En-
hanced levels of MIF immunolabel started to accumulate
24 h after infection and increased toward the end of the
infection course. Detailed analysis of the intracellular
MIF distribution revealed that MIF protein accumulated
FIG. 3. MIF secretion by human fibroblasts. MIF release was ana-
lyzed by sandwich ELISA of supernatants collected at the indicated
time points from uninfected fibroblasts ( ), from HCMV-infected cells
(), from fibroblasts incubated with UV-inactivated virus ( ), and from
HCMV infected cells which were incubated in the presence of PAA ( ).
Measurements were performed in triplicate cultures; data shown are
means  SD of one representative experiment out of a group of five
separate experiments with similar results.
FIG. 4. Intracellular MIF content in uninfected (Ctrl) and virus-infected (HCMV) human fibroblasts. (A, B) MIF-immunofluorescence was detected with
anti-MIF IgG at the indicated time points as described under Materials and Methods. (A) Kinetics if intracellular MIF-immunofluorescence in normal
and HCMV-infected fibroblasts. (B) Close up shows highest MIF accumulation at 72 h after virus infection (indicated by white arrowheads) in
association with the nucleus. (C) Western blot obtained from cell lysates after viral infection (0–96 h). Four micrograms of protein was transferred onto
nitrocellulose membrane and MIF detected with polyclonal antibodies against human MIF as outlined under Materials and Methods.
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in a prominent patch at various size in association with
the nucleus (Fig. 4B). The virus-dependent induction of
intracellular MIF was also confirmed by Western blot
from cell lysates (Fig. 4C)
DISCUSSION
In recent years, MIF has been described in numerous
studies to play a critical role in inflammation and infec-
tion. Nevertheless, the present study, for the first time,
addressed the question whether HCMV infection could
modulate the expression of MIF. A possible link between
HCMV infection and the regulation of MIF was fostered
on one hand by the concept that the pathophysiologic
events of HCMV activation in immunosuppressed pa-
tients is associated with the ability of the virus to induce
the production of pro-inflammatory mediators, and on the
other hand by a recent study which showed that MIF is
markedly upregulated during renal allograft rejection in
humans (Lan et al., 1998). Therefore, it appears to be
conceivable that the apparent increase of MIF during
allograft rejection could also be a direct effect of HCMV
activation.
Infection of human fibroblasts resulted in a rapid and
sustained induction of MIF transcripts and protein. The
induction of MIF protein was still observed when the
fibroblasts were infected with purified virus which ruled
out that the increase of MIF was due to an activity found
in the medium of infected cells. This outcome has been
recently described for the CC chemokine MCP-1, i.e., the
induction of this cytokine was completely abolished,
when human fibroblasts were infected with purified virus
(Hirsch and Schenk, 1999). The inactivation of HCMV by
UV-irradiation completely abrogated the induction of in-
tra- and extracellular MIF production in HFF, implying
that productive infection is required to promote this im-
mune response. In contrast to these results, the HCMV-
mediated increase of other cytokines may also occur in
the absence of productive viral infection. In this context,
the infection of primary human fibroblasts with either
HCMV alone or HCMV-UV gave rise to a similar induction
of RANTES or IL-6 (Michelson et al., 1997; Carlquist et al.,
1999).
The kinetics of MIF protein production during HCMV
infection points out to an efficacious immune modulation,
in which lymphocytes and monocytes are initially re-
cruited by the early release of chemokines to sites of
infection and locally activated by increasing concentra-
tions of MIF.
It has been recently established that the up-regulation
of MIF during human renal allograft rejection is closely
related to the severity of the rejection response, thus
playing an essential role in the pathogenesis of the graft
rejection (Lan et al., 1998). Our in vitro model of HCMV-
mediated induction of MIF indicates, that at least a part
of the enhanced levels of MIF seen in transplant rejec-
tion may directly derive from HCMV activation.
HCMV can frequently infect the central nervous sys-
tem in the setting of an infection with the human immu-
nodeficiency virus (HIV) (McCutchan, 1995). Virus in-
duced production of potentially neurotoxic cytokines,
such as IL-1, IL-6, and TNF- may contribute to the
neurological manifestations of HCMV infection in per-
sons with AIDS (Pulliam et al., 1995). Given the signifi-
cant pro-inflammatory effects of MIF, we consider the
possibility that HCMV-dependent MIF production in the
brain could also play a role in the pathogenic mechanism
of CNS damage in AIDS patients.
An interesting link between the activities of HCMV and
MIF might arise from the interaction with the tumor sup-
pressor protein p53. Previous studies have convincingly
proven the ability of CMV to inhibit the action of p53
(Speir et al., 1994; Tsai et al., 1996; Wang et al., 2001). MIF
has been also identified to be capable of functionally
inactivating p53 (Hudson et al., 1999). This allows to
speculate that the effective inactivation of P53 in vivo is
not exclusively mediated by viral interactions alone and
might also require the action of virus-induced MIF.
MATERIALS AND METHODS
Cells
HFFs were cultured in Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 10% fetal calf se-
rum (FCS), 2 mM glutamine, 50 U/ml penicillin, and 50
g/ml streptomycin at 37°C and 5% CO2. For kinetics,
confluent HFF cells between passages 20 and 25 were
washed with PBS and maintained in FCS-free DMEM
supplemented with 2 mM glutamine, 50 U/ml penicillin,
and 50 g/ml streptomycin. HFF were infected with ac-
tive HCMV, purified HCMV, UV-inactivated HCMV and
HCMV in the presence of 200 g/ml phosphonoacetic
acid (PAA) (Wang et al., 2001). Monolayer cultures (1.5–
5  106 cells each) were harvested by scraping after
collection of the medium.
Virus
A laboratory strain AD169 of HCMV was used. For
experimental infection a multiplicity of infection (m.o.i.) of
about 3 was used. Virus titrations were performed by the
endpoint dilution method using indirect immunofluores-
cence for detection of immediate early HCMV antigen
with a commercial mAb (Radsak et al., 1990).
HCMV was inactivated by exposure to a 254-nm ger-
micidal UV lamp at a distance of 8 cm for 60 min (HCMV-
UV). The ability of the UV-inactivation treatment to render
HCMV noninfectious was verified by the failure to pro-
duce characteristic cytopathic effect (CPE). To inhibit
HCMV DNA synthesis infected cells were treated con-
tinuously with 200 g/ml PAA (Huang, 1975) starting
immediately after virus adsorption.
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In addition, virus particles were purified by velocity
centrifugation in a sucrose gradient as previously de-
scribed (Stinski, 1976). Briefly, 50 ml of an infected cell
supernatant prepared as described above was under-
layed with a 7-ml sucrose cushion containing 20% su-
crose, 50 mM Tris–HCl (pH 7.2), 1 mM MgCl2. Virions
were pelleted by centrifugation at 24,000g for 16 h at 4°C
temperature. Pellets were resuspended in DMEM to pro-
duce a purified virus stock.
Antibody
Anti-MIF IgG was prepared from rabbit serum raised
to human rMIF. Anti-MIF IgG was purified from serum by
protein A affinity chromatography following the manufac-
turer’s instructions (Pierce, Rockford, IL).
Human rMIF
Human MIF cDNA was cloned into pET-17b vector
(Novagen, Madison, WI) and expressed in Escherichia
coli BL-21 (DE3) strain after induction with 0.4 mM iso-
propyl -D-thiogalactoside (IPTG) and purified from the
soluble fraction of the cell lysate by two-step HPLC: (1)
size-exclusion HPLC on Bio-Sil TSK 250 (Bio-Rad, Mu-
nich, Germany), and (2) ion-exchange HPLC on Ultropac
TSK CM-3SW (LKB/Pharmacia, Germany).
Northern blot analysis
For Northern blot analysis, the cells were harvested at
different time points as indicated, and the total RNA was
isolated with Trizol (Gibco/BRL). RNA (5 g) was electro-
phoresed through 1% agarose–formaldehyde gels, trans-
ferred onto positively charged nylon membranes (Boeh-
ringer, Mannheim, Germany), and hybridized with a
human MIF riboprobe. Probes were labeled with digoxi-
genin using the DIG RNA labeling kit (Boehringer).
Chemiluminescence detection was achieved according
to the instructions for the use of the CDP-Star (Tropix,
Bedford, MA) chemiluminescent substrate for alkaline
phosphatase. Blots were exposed to Hyperfilm MP au-
toradiographic film and the films were processed in an
Optimax automatic developing machine.
To confirm equal loading of the RNA samples, equal
amounts of total RNA were blotted onto nitrocellulose
membranes and stained with methylene blue as de-
scribed (Lan et al., 1998).
MIF-Western blot
Supernatants were collected from mock- or HCMV-
infected cells at the times indicated under Results and in
the figures. Upon sampling, protease inhibitor cocktail
(Boehringer Mannheim, Germany) was added and the
supernatants were clarified by centrifugation at 2000g for
5 min at 4°C and 2-ml aliquots were concentrated in
Centricon-10 concentrators (Amicon, Beverly, MA) ac-
cording to the operating manual. The concentrated sam-
ples were kept frozen at 80°C until tested. Intracellular
protein was isolated by the Trizol method as outlined in
the manufacturer’s manual. Protein content of the cell
lysates was quantified using the BCA kit (Pierce, Rock-
ford, IL).The concentrated supernatants and intracellular
protein were separated by SDS–PAGE and blotted onto
Optitran BA-S 83 nitrocellulose membranes (Schleicher
& Schuell, Dassel, Germany) using the Nu PAGE precast
polyacrylamide minigel system (Novex, San Diego, CA)
according to the manufacturer’s instructions. Western
blotting was performed according to the instructions of
the Super Signal Ultra Western blotting kit (Pierce, Rock-
ford, IL). Briefly, the blots were incubated with the rabbit
anti-human MIF IgG (2.5 g/ml). The membranes were
washed 4 with PBS containing 0.5% Tween 20 and
were then incubated for 1 h with horseradish-peroxidase
conjugated secondary antibody (goat anti-rabbit IgG; di-
lution 1:250,000). The blots were washed 4 10 min and
incubated for 5 min in Super Signal substrate working
solution (Pierce) and exposed to Bio Max MR autoradio-
graphic film (Kodak, Rochester, NY). The films were pro-
cessed in an Automax automatic developing machine
(MS Laborgeraete, Heidelberg, Germany).
MIF-ELISA
For measurement of MIF protein, unconcentrated su-
pernatants from HCMV-infected HFF were analyzed by
sandwich ELISA, employing a monoclonal anti-human
MIF capture antibody, biotinylated goat anti-human MIF
IgG detection antibody (R & D Systems, Wiesbaden,
Germany), and purified human rMIF as standard.
MIF-immunofluorescence assay
Cells were permeabilized and fixed by acetone/meth-
anol (1:1) for 30 min at 4°C. Visualization of intracellular
MIF expression was carried out by indirect immunofluo-
rescence with rabbit anti-human IgG and a secondary
fluorescein isothiocyanate (FITC)-labeled swine anti-rab-
bit IgG antibody (Dako A/S, Denmark) for 30 min at 4°C.
For documentation, the photographic equipment of a
Zeiss Axiopot microscope and Spot camera (Diagnostic
Instruments, Version 2.1.2 for Windows 95/98/NT) and
Spot 32 program were used.
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